Product Details

Actemra 162 mg**

Tocilizumab
162 mg/0.9 mL
Solution for injection

ROA

Subcutaneous

Applicant Name

Roche Products Limited

NRN

A6-100070

Status

Active


Composition

Each single-dose prefilled syringe contains: Tocilizumab 162 mg in 0.9 mL solution. Tocilizumab is a humanized IgG1 monoclonal antibody against the human interleukin-6 (IL-6) receptor produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology  

ATC Code

L04AC07  

Product Category

Vaccines and Biologics

Marketing Category

Prescription-only Medicine (POM)  

Packsize

0.9 mL x 4’s (in pre-filled syringed)  

Product Description

Solution for injection in single-dose pre-filled syringe for SC injection. A preservative-free, sterile clear, colourless to pale yellow solution

Manufacturer Name

Vetter Pharma-Fertigung GmbH & Co. KG

Manufacturer Country

GERMANY  

Approval Date

2023-02-19  

Expiry Date

2028-02-18